04-05-2018 | Oncology | News | Article
In other news
This month we bring you a round-up of four trials investigating nivolumab in diverse tumors, including non-small-cell lung cancer, Hodgkin lymphoma, and nasopharyngeal carcinoma. Read on to find out more.
12-12-2017 | Lymphoma | News | Article
Brentuximab vedotin may improve outcome in advanced Hodgkin lymphoma
A treatment regimen incorporating the anti-CD30 antibody–drug conjugate brentuximab vedotin is more effective than standard therapy with doxorubicin, bleomycin, vinblastine, and dacarbazine when used as a frontline therapy in patients with advanced Hodgkin lymphoma, phase III trial data show.
01-11-2017 | Lymphoma | News | Article
Breast implant-associated lymphoma characterized
US researchers have detailed the pathophysiology, clinical presentation, and management of breast implant-associated anaplastic large cell lymphoma in a move to educate healthcare professionals dealing with this rare but increasingly common diagnosis.
24-08-2017 | Oncology | News | Article
Crizotinib shows promise in pediatric ALCL and IMT
Pediatric patients with anaplastic large cell lymphomas and inflammatory myofibroblastic tumors respond well to crizotinib therapy, with more than 80% experiencing an objective response, US researchers report.
19-05-2017 | Oncology | News | Article
In other news
Here we report on osteoporosis therapy in breast cancer patients, the feasibility of an alternative formulation of rituximab in follicular lymphoma, the effects of extended use of anamorelin on lung cancer-related cachexia, and the 3-year results of the COMBI-d trial.
T cells/© cgtoolbox / Getty Images / iStock, IV drip_patient's hand/© sippakorn yamkasikorn / iStock / Thinkstock, IV drip 2/© Anna Jurkovska / Fotolia